IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

FDA Probed Over Approval of Ranbaxy Drugs

11:02 AM MDT | July 29, 2008 | Deepti Ramesh

AHouse panel is questioning whether the Food and Drug Administration (FDA) has approved and knowingly allowed drugs suspected of being manufactured in gross violation of cGMP rules to be sold in the U.S. by Ranbaxy, a unit of Ranbaxy Laboratories Ltd. (Gurgaon, India). The House Energy and Commerce Committee says its actions are in response to a U.S. Justice Department (DOJ) and Attorney’s Office motion recently filed in a federal court naming the drugmaker. “Allegation from reliable sources and supporting documents indicate a pattern of systematic...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa